News Endymed Ltd TEL AVIV STOCK EXCHANGE

Equities

ENDY

IL0011010217

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 12:24:09 25/04/2024 BST			5-day change	1st Jan Change
325 ^ILa	+0.12%		+0.03%	+12.46%

03-20	Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-22	CI
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/08/23	CI
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	24/05/23	CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
Endymed Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	24/11/22	CI
Endymed Ltd Receives FDA Approval for Marketing and Sales of its Brand-New Laser Based Hair Removal Device	20/10/22	CI
Endymed Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Endymed Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	15/05/22	CI
Endymed Ltd Appoints Bill Scott as US Subsidiary President, Endymed Inc	06/04/22	CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	09/03/22	CI
Endymed Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	25/08/21	CI
Endymed Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	22/03/21	CI
Endymed Medical Ltd. announced that it has received $7 million in funding from OHMK Medical Technology Co. Ltd.	03/08/14	CI
Endymed Medical Ltd. announced that it expects to receive $7 million in funding from OHMK Medical Technology Co. Ltd.	09/06/14	CI
Endymed Ltd. Obtains FDA's First Approval of a RF Device for Home Treatment for Wrinkle Reduction	22/08/13	CI
Endymed Medical Ltd. acquired Applisonix, Ltd. (TASE: APLS) in a reverse merger transaction.	28/02/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer